tiprankstipranks
Advertisement
Advertisement
BeOne Medicines price target raised to $418 from $416 at Truist
PremiumThe FlyBeOne Medicines price target raised to $418 from $416 at Truist
8d ago
BeOne Medicines price target raised to $430 from $420 at Guggenheim
Premium
The Fly
BeOne Medicines price target raised to $430 from $420 at Guggenheim
8d ago
BeOne Medicines price target lowered to $450 from $451 at RBC Capital
Premium
The Fly
BeOne Medicines price target lowered to $450 from $451 at RBC Capital
8d ago
BeOne Medicines: Buy Rating Reiterated on Strong Q2 Beat, Raised 2026 Outlook and Unchanged $395 Price Target
PremiumRatingsBeOne Medicines: Buy Rating Reiterated on Strong Q2 Beat, Raised 2026 Outlook and Unchanged $395 Price Target
9d ago
BeOne Medicines reports Q2 adjusted EPS $3.84, consensus $1.63
Premium
The Fly
BeOne Medicines reports Q2 adjusted EPS $3.84, consensus $1.63
9d ago
BeOne Medicines raises FY26 revenue view to $6.6B-$6.8B from $6.3B-$6.5B
Premium
The Fly
BeOne Medicines raises FY26 revenue view to $6.6B-$6.8B from $6.3B-$6.5B
9d ago
BeOne Medicines Halts Early BGB-21447 Cancer Trial: What Investors Should Watch
PremiumCompany AnnouncementsBeOne Medicines Halts Early BGB-21447 Cancer Trial: What Investors Should Watch
1M ago
BeOne Medicines price target lowered to $403 from $409 at Barclays
Premium
The Fly
BeOne Medicines price target lowered to $403 from $409 at Barclays
1M ago
BeOne Medicines upgraded to Buy from Hold at Jefferies
Premium
The Fly
BeOne Medicines upgraded to Buy from Hold at Jefferies
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100